Provides Opinion & Testimony In:
Pharmaceutical Medical Biotechnology Nutraceutical, Pharmaceutical, Clinical Pharmacology, Pharacodynamics, Medicine, Pharmacy, Overdose, Pharmacology, Biopharmaceutics, Pharmacokinetics, Toxicokinetics, Biotechnology, Biotechnology Bioavailability Bioequivalence, Drug Interactions, Pharmaceutical Drug Overdose, Drug Abuse, Drug Dosage Forms, Drug Reactions, Drug Toxicity, Drug Metabolism, Drug Regulatory Affairs, Pharmacoeconomics Aspects Of Biomedical Services, Rates Of Drug Entry Body, Rates Of Drug Exit Body, Drug Activity, Drug Side Effects, Drug Interactions, Pharmacology, Drug Overdose, Drug Abuse, Toxicology, Data Analysis, Pharmaceutical Dosage Form Issues, Drug Labeling, Standards Of Conduct, Due Diligence, Malpractice, Patent Issues, Regulatory Affairs, Laboratory Tests, Laboratory Evaluations
Expert Witness No.953
Fields of Specialization
Pharmaceutical, Clinical Pharmacology, Pharacodynamics, Pharmacy, Overdose, Pharmacology, Biopharmaceutics, Pharmacokinetics, Toxicokinetics, Biotechnology, Bioavailability/Bioequivalence, Drug Interactions, Drug Overdose, Drug Abuse, Drug Dosage Forms, Drug Reactions and Toxicity, Drug Metabolism, Drug Regulatory Affairs, Pharmacoeconomics and other aspects of biomedical services, rates of drug entry and exit from the body, drug activity & side-effects, drug interactions, pharmacology, drug-overdose, drug abuse, toxicology, data analysis, dosage form issues, drug labeling, standards of conduct, due diligence, malpractice, case analysis, patent issues, regulatory affairs, laboratory tests and evaluations
B.S. 1965: Temple University School of Pharmacy
M.S. 1969: Temple University School of Pharmacy
Ph.D. 1973: University of California at San Francisco, School of Pharmacy
1972 – 74 Assistant Professor, Ohio State University, College of Pharmacy, Columbus, OH.
1974 – 77 Senior Scientist, Dept. of Biochemistry & Drug Metabolism, Hoffmann – La Roche Inc., Nutley, NJ.
1977 – 80 Owner, Manager & Clinical Pharmacist, Pennyroyal Apothecary, Vallejo, CA.
1980 – 85 Associate Professor, University of Connecticut, School of Pharmacy, Storrs, CT.
1985 – 92 Research Associate (Scientist), (Marion) Merrell Dow Inc., Drug Metabolism Dept., Cincinnati, OH.
1992 – 1994 Director, Clinical Pharmacokinetics, Wyeth – Ayerst Research, Phila., PA.
1994-1996 Director/Distinguished Scientist, Pharmacokinetics, Otsuka America Pharmaceutical, Inc., Rockville, MD.
1996-Present: Principal, Private Company, Pharmaceutical, Biotechnology and Nutraceutical Consulting & Development
Fellow, American Assoc. for the Advancement of Science (1989)
Fellow, American Association of Pharmaceutical Scientists (1989)
Fellow, American Foundation for Pharmaceutical Education (1998)
Adjunct Professor, Georgetown University School of Medicine, Department of Clinical Pharmacology
American Association of Pharmaceutical Scientists
American Soc for Pharmacol and Exp Therapeutics
International Society for the Study of Xenobiotics
Human and Ecological Risk Assessment: Editorial Board
International Journal of Pharmaceutics: Editorial Board (tenure ended 9/00)
Pharmaceutical Research: Editorial Board (1994-1997)
J Pharmacy & Pharmaceutical Sciences: Editorial Board
Scientific Reviewer to the following Journals:
Journal of Pharmaceutical Sciences
International Journal of Pharmaceutics
Biopharmaceutics & Drug Disposition
Drug Metabolism Reviews
Journal of Pharmacology & Experimental Therapeutics
Drug Metabolism & Disposition
Fundamental and Applied Toxicology
Member (1991,92), Fellows Selection Committee, Pharmacokinetics, Pharmacodynamics & Drug Metabolism Division, American Association of Pharmaceutical Scientists
Founding Member (1992-Present), National Scientific Advisory Committee, Biological Effects of Low Level Exposures
Over 75 Scientific Publications — Available Upon Request